PDF File - The Indian Society for Parasitology

26 Banyal and Elangbamantibodies induced by intranasal immunization of mice with Chopra N, Biswas S, Thomas B, Sabhnani L and Rao DN. 2000.Plasmodium vivax Pvs 25 co-administered with cholera Inducing protective antibodies against ring-infectedtoxin completely block parasite transmission to mosquitoes. erythrocyte surface peptide antigen of PlasmodiumVaccine 21: 3143-3148.falciparum using immunostimulating complex (ISCOMS)Artavanis-Tsakonas K, Tongren JE and Riley EM. 2003. Thedelivery. Med Microbiol Immunol 189: 75-83.war between the malaria parasite and the immune system : Couper KN, Phillips RS, Brombacher F and Alexander J. 2005.immunity, immunoregulation and immunopathology. Clin Parasite-specific IgM plays a significant role in theExp Immunol 133: 145-152.protective immune response to asexual erythrocytic stagePlasmodium chabaudi AS infection. Parasit Immunol 27:Audran R, Cachat M, Lurati F, Soe S, Leroy O, Corradin G,171-180.Druilhe P and Spertini F. 2005. Phase 1 malaria vaccine trialwith a long synthetic peptide derived from the Mz surface D'Alessandro U, Leach A, Drakeley CJ, Bennett S, Olaleye BD,protein 3 antigen. Infect Immun 73: 8017-8026.Pegan GW, Jawara M, Langerock P, George MO, Targett GAand Greenwood BM. 1995. Efficacy trial of malaria vaccineBanyal HS and Inselburg J. 1985. Isolation and characterizationSPf 66 in Gambian infants. Lancet 346: 462-467.of parasite inhibitory Plasmodium falciparum monoclonalantibodies. Am J Trop Med Hyg 34: 1055-1064.Daly TM, Burns Jr, JM and Long CA. 1992. Comaprison of thecarboxy-terminal, cysteine-rich domain of the Mz surfaceBastianelli G and Bignami A. 1899. Sullo sviluppo dei parassitiprotein-1 from several strains of Plasmodium yoelii. Moldella terzana nell' Anopheles claviger. Atti Soc Studi MalarBiochem Parasitol 52: 279-282.1: 28-49.Daubersies P, Thomas AW, Millet P, Brahimi K, LangermansBlack CG, Tieqiao W, Wang L, Hibbs AR and Coppel RL. 2001.JAM, Ollomo B, Benmohamed L, Slierendreg, B, Eling W,Mz surface protein 8 of Plasmodium falciparum containsVan Belkum A, Dubreuil G, Meis JFGM, Guerin-Marchandtwo epidermal growth factor-like domains. Mol Biochem C, Cayphas S, Cohen J, Gras-Masse H and Druilhe P. 2000.Parasitol 114: 129-262.Protection against Plasmodium falciparum malaria inBlackman MJ, Scott-Finningan TJ, Shai S and Holder AA. chimpanzees by immunization with the conserved pre-1994. Antibodies inhibit the protease-mediated processingerythrocytic liver stage antigen 3. Nature Med 6: 1258-of a malaria Mz surface protein 1. J Exp Med 180: 389-393.1263.Bojang KA, Milligan PJM, Pinder M, Vigneron L, Alloueche A,Dodoo DF, Omer F, Todd J, Akanmor B, Koram K and RileyKester KE, Ballou WR, Conway DJ, Reece WHH, GothardEM. 2002. Absolute levels and ratios of pro-inflammatoryP, Yamuah L, Delchambre M, Voss G, Greenwood BM, Hilland anti-inflammatory cytokine production in vitro predictAVS, McAdam KPWJ, Tornieporth N, Cohen J and Dohertyclinical immunity to P. falciparum malaria. J Infect Dis 185:T. 2001. Efficacy of RTS, S/AS02A malaria vaccine against971-979.Plasmodium falciparum infection in semi-immune adult Doherty JF, Pinder M, Tornieporth N, Carton C, Vigneron L,men in The Gambia: a randomized trial. Lancet 358: 1927- Milligon P, Ballou WR, Holland CA, Kester KE, Voss G,1934. Momin P, Greenwood BM, McAdam KP, and Cohen J.Bouharoun-Tayoun H, Oeuvray C, Lunel F and Druilhe P. 1995.1999. A phase I safety and immunogenicity trial with thecandidate malaria vaccine RTS, S/SBAS 2 in semi-immuneMechanisms underlying the monocyte-mediated antibodyadultsin The Gambia. Am J Trop Med Hyg 61: 865-868.dependent killing of Plasmodium falciparum asexual bloodstages. J Exp Med 182: 409-418.Doolan DL and Hoffman SL. 1999. NK Cells and IL-12 arerequired for antigen-specific adaptive immunity againstBoyd MF. 1949. 'Malariology'. Saunders, Philadelphia,malaria initiated by CD8+ T cells. J Immunol 163: 884-892.Pennsylvania.Doolan DL and Hoffman SL. 2000. The complexity ofBurns JM Jr, Flaherty PR, Romero MM and Weidanz WP. 2003.protective immunity against liver-stage malaria. J ImmunolImmunization against Plasmodium chabaudi malaria using165: 1453-1462.combined formulations of apical membrane antigen-1 andMz surface protein-1. Vaccine 21: 1843-1852.Doolan DL and Hoffman SL. 2001. DNA-based vaccinesagainst malaria: status and promise of the Multi-StageCavacini L, Parke LA and Weidanz WP. 1990. Resolution ofMalaria DNA vaccine Operation. Int J Parasitol 31: 753-acute malarial infections by T-cell dependent non-antibody762.mediated mechanisms of immunity. Infect Immun 58: 2946-2950. Druilhe P, Spertini F, Soesoe D, Corradin G, Mejia P, Singh S,Audran R, Bouzidi A, Oeuvray C and Roussilhon C. 2005. AChelimo K, Ofulla A, Narum DL, Kajura JW, Lanar DE andmalaria vaccine that elicits in humans antibodies able to killJohn CC. 2005. Antibodies to Plasmodium falciparumPlasmodium falciparum. PLOS Med 2: e344.antigens vary by age and antigenin children in a malariaholoendemicarea of Kenya. Pediatric Infect Dis J 24: 680- Egan JE, Weber JL, Ballou WR, Hollingdale MR, Majarian684. WR, Gordon DM, Maloy WL, Hoffman SL, Wirtz RA,Schneider I, Woollett GR, Young JF and Hockmeyer WT.